Nanovis, led by CEO Matt Hedrick, invents, acquires and commercializes technologies intended to reduce fixation- and infection-related complications in spinal surgery. The company sells nanotechnology-enhanced spinal implants and commercializes science-driven platforms, including the deeply porous scaffold available in the FortiCore® line of interbody fusion devices. Its product portfolio also includes an advanced nanotube-surface technology and surface technologies with anti-colonization and bactericidal capabilities. Nanovis is responding to increased demand from surgeons and distributors for its implants. The company completed a $5.5M funding round and plans to use the proceeds to meet increased working capital and sales needs. The company is headquartered in Carmel, Indiana.

Total raised

$6M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2018